Washington, Aug 17 (ANI): Using human induced pluripotent stem cells (iPSCs), researchers at the Buck Institute for Age Research have successfully treated rodents afflicted with Parkinson's Disease (PD).
The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications.
Parkinsons Disease
Parkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson's disease are correctable to an extent.
Advertisement
Human iPSC's are a "hot" topic among scientists focused on regenerative medicine.
"These cells are reprogrammed from existing cells and represent a promising unlimited source for generating patient-specific cells for biomedical research and personalized medicine," said Dr. Xianmin Zeng Zeng, lead author of the study.
![Parkinson Disease at a Younger Age Attributed to Gene Abnormality]( "Parkinson Disease at a Younger Age Attributed to Gene Abnormality")
According to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology, people with a certain gene mutation
"Human iPSCs may provide an end-run around immuno-rejection issues surrounding the use of human embryonic stem cells (hESCs) to treat disease. They may also solve bioethical issues surrounding hESCs," he added.
Researchers used human iPSCs that were derived from skin and blood cells and coaxed them to become dopamine-producing neurons.
Dopamine is a neurotransmitter produced in the mid-brain, which facilitates many critical functions, including motor skills. Patients with PD lack sufficient dopamine.
Researchers transplanted the iPSC-derived neurons into rats that had mid-brain injury similar to that found in human PD.
The cells became functional and the rats showed improvement in their motor skills.
Zeng said this is the first time iPSC-derived cells have been shown to engraft and ameliorate behavioural deficits in animals with PD.
Dopamine-producing neurons derived from hESCs have been demonstrated to survive and correct behavioural deficits in PD in the past.
"Both our functional studies and genomic analyses suggest that overall iPSCs are largely similar to hESCs," said Zeng.
The study has been published in the on-line edition of the journal Stem Cells.
Source: ANI
Parkinson Disease at a Younger Age Attributed to Gene Abnormality
According to a study published in the September 18, 2007, issue of Neurology, the medical journal of the American Academy of Neurology, people with a certain gene mutation
Advertisement
"Human iPSCs may provide an end-run around immuno-rejection issues surrounding the use of human embryonic stem cells (hESCs) to treat disease. They may also solve bioethical issues surrounding hESCs," he added.
Researchers used human iPSCs that were derived from skin and blood cells and coaxed them to become dopamine-producing neurons.
Dopamine is a neurotransmitter produced in the mid-brain, which facilitates many critical functions, including motor skills. Patients with PD lack sufficient dopamine.
Researchers transplanted the iPSC-derived neurons into rats that had mid-brain injury similar to that found in human PD.
The cells became functional and the rats showed improvement in their motor skills.
Zeng said this is the first time iPSC-derived cells have been shown to engraft and ameliorate behavioural deficits in animals with PD.
Dopamine-producing neurons derived from hESCs have been demonstrated to survive and correct behavioural deficits in PD in the past.
"Both our functional studies and genomic analyses suggest that overall iPSCs are largely similar to hESCs," said Zeng.
The study has been published in the on-line edition of the journal Stem Cells.
Source: ANI
Nose may Hold Key to Parkinson's Cure
A new study from Griffith University suggests that Parkinson's patients' nose may harbour a cure for the disease.
Advertisement
 Robot Controlled by Cables may Help in Stroke and Parkinson’s PatientsA unique robotic device has been developed by experts at Florida Atlantic University. This robot may prove useful in rehabilitating patients suffering from Parkinson's disease and stroke. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
Consuming a diet rich in saturated fats triggers persistent, low-level inflammation within the body, ultimately contributing to the onset of metabolic syndrome.
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
